Skip to main content
OpenTrials
Completed

NCT Number: NCT02475850

Strategies to Reduce Injuries and Develop Confidence in Elders

The aim of this pragmatic cluster-randomized trial is to determine the effectiveness of an evidence-based, patient-centered multifactorial fall injury prevention strategy in community dwelling older adults at risk of falls recruited from 86 primary care practices around the U.S.

Completed

Looking for future studies?

Notify Me

Key information

Age range

70 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Healthcare Partners, Torrance, California, United States

Loading trial locations.

About this study

Objective: To determine the effectiveness of an evidence-based, patient-centered multifactorial fall injury prevention strategy implemented within primary care practices using usual health care resources

Design: This study is a cluster randomized, parallel group superiority trial with practices stratified by healthcare system and patients nested within practices. The unit of randomization is the practice.

Study Duration: The total study duration is 5 years. Recruitment will take place over 20 months, with follow-up taking place for 24 months - 44 months depending on date of enrollment.

Trial Sites: 86 primary care practices that are part of 10 trial sites located around the U.S.: The Partners' Health Care System; Essentia; Hopkins Health Care System; HealthCare Partners; Reliant Health Care System; Mount Sinai Health Care System; University of Pittsburgh Health Care System; University of Texas Medical Branch Health Care System; University of Iowa Health Care System; University of Michigan Health Care System.

Number of Subjects: The original target sample size was 6,000 participants enrolled in 86 practices to provide 90% power to detect a 20% reduction in the rate of the primary outcome with intervention relative to control. The study was originally designed for a study duration of 36 months with 18 months of recruitment and a minimum of 18 months of follow-up. The study was extended to a 44 month study (20 months of recruitment and a minimum 24 month of follow-up). For a 44 month trial, it was estimated that a sample size of 5,322 subjects would provide 90% power to detect a 20% reduction in the rate of the primary outcome with the intervention relative to control.

Main Inclusion Criteria Community-living persons, 70 years or older, who are at increased risk for serious fall injuries.

Intervention: An evidence-based patient-centered intervention that will combine elements of a multifactorial, risk factor-based, standardly-tailored fall prevention strategy developed at Yale, practice guidelines offered by the Center for Disease Control's (CDC's) "STEADI" toolbox (Stopping Elderly Accidents, Disability and Injury) and the joint American Geriatrics Society/British Geriatrics Society guidelines, and Assessing Care of Vulnerable Elders (ACOVE) practice change approach. The fall prevention strategies will be systematically implemented into clinical practice using: delivery system design to improve quality (Co-management); decision support (algorithms); information systems (software); self-management support (patient/caregiver engagement and activation); and linkage to community-based resources.

Primary Outcome: The primary outcome is adjudicated serious fall injuries, operationalized as a fall resulting in: (1) (fracture other than thoracic/lumbar vertebral; joint dislocation; or cut requiring closure) AND any medical attention; OR (2) (head injury; sprain or strain; bruising or swelling; or other) requiring hospitalization.

Primary Analysis: The risk of any serious fall injury (i.e., time to first event) will be analyzed using a survival model that incorporates competing risks (due to death) and clustering. In this analysis, participants who are lost to follow-up without a prior serious fall-related injury will be censored at their date last seen. In a sensitivity analysis, the investigators will adjust for the pre-specified set of baseline covariates to examine their influence on the intervention effect.

Secondary Outcomes: All self-reported falls, all self-reported fall-related injuries, and measures of well-being.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The patient is at least 70 years of age.
  • The patient must answer 'yes' to one or more of the following questions:
  • Have you fallen and hurt yourself in the past year?
  • Have you fallen 2 or more times in the past year?
  • Are you afraid that you might fall because of balance or walking problems?

Exclusion criteria

  • The patient is enrolled in hospice.
  • The patient resides in a nursing home.
  • The patient is not capable of providing informed consent (or assent), and a proxy is not available.
  • The patient does not speak English or Spanish

Treatment and study plan

Evidence-based tailored fall prevention

Other

Usual Care

Other

Primary outcomes

  1. First Adjudicated Serious Fall-Related Injury

    Time frame: Enrollment through last completed follow-up or death interview (max 44 months)

    Number of first adjudicated serious fall-related injury serious fall-related injury events per 100 per years of follow-up.

Secondary outcomes

  1. First Self-reported Fall-related Injury

    Time frame: Enrollment through last completed follow-up or death interview (max 44 months)

    Number of first self-reported fall-related injuries per 100 per years of follow-up

  2. Time to Self-reported Falls

    Time frame: these data were not collected

    ** data for this outcome was not collected

  3. Physical Function

    Time frame: measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores

    Late Life Function and Disability Instrument (LL-FDI) function score. The scores are on a 0-100 scale, higher score = better function. The measure reported is the mean of scores at the 12-month and 24-months follow-up assessment

  4. Disability

    Time frame: measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores

    Late Life Function and Disability Instrument (LL-FDI) disability score. The scores are on a 0-100 scale, higher score = less disability. The measure reported is the mean of scores at the 12-month and 24-months follow-up assessment

  5. Anxiety

    Time frame: Measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores.

    Patient-reported Outcome Measure Information System (PROMIS) Anxiety subscale. Measured on a 8-40 Scale, higher score = more anxiety.

  6. Depression

    Time frame: Measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores.

    PROMIS depression subscale. Measured on a 8-40 Scale, higher score = more depression.

  7. Fear of Falling

    Time frame: Measured at 12-month and 24-month follow-up assessments, reported score is an average (mean) of the follow-up scores.

    Falls Efficacy Scale. Measured on a 10-40 Scale, higher score = more fear of falling.

Sponsors and collaborators

Lead sponsor

Brigham and Women's Hospital

Other

Collaborators

  • Essentia Health
  • Healthcare Partners
  • Johns Hopkins University
  • National Institute on Aging (NIA)
  • National Institutes of Health (NIH)
  • Partners HealthCare
  • Patient-Centered Outcomes Research Institute
  • Reliant Medical Group
  • Sinai Health System
  • The University of Texas Medical Branch, Galveston
  • University of California, Los Angeles
  • University of Iowa
  • University of Michigan
  • University of Pittsburgh Medical Center
  • Wake Forest University
  • Yale University

Registry information

Official study title

Randomized Trial of a Multifactorial Fall Injury Prevention Strategy

Acronym: STRIDE

Important dates

Study start
2015
Primary completion
2019
Study completion
2020
First posted
Jun 19, 2015
Registry last updated
Mar 3, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.